Category: basic life sciences retractions

Widely used U.S. government database delists cancer journal

The U.S. government biomedical research database MEDLINE no longer includes a cancer journal with a storied past.

Starting August 2017, researchers looking up journals indexed in MEDLINE (which is accessed via PubMed) could no longer find new articles published by Oncotarget, once included on the now-defunct list of possibly predatory journals compiled by librarian Jeffrey Beall.

Joyce Backus, the National Library of Medicine’s Associate Director for Library Operations, declined to say why Oncotarget had been deselected from MEDLINE:

Continue reading Widely used U.S. government database delists cancer journal

Unnamed institution makes baffling retraction requests, journals comply

Two journals are retracting papers published by researchers affiliated with Children’s Hospital Los Angeles (CHLA).

To be frank, we’re baffled by most of this story. The retraction notices say “the institution” requested the retractions, but don’t name it; the first and last authors are also affiliated with the University of Southern California, as well as CHLA. Neither journal will say which institution sent the request, and USC and CHLA have each declined to comment on the retractions.

Here’s what we do know: Continue reading Unnamed institution makes baffling retraction requests, journals comply

Caught Our Notice: An “absolutely perfect retraction”

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, more than 1300 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at [email protected].

Title: Skeletal muscle-specific CPT1 deficiency elevates lipotoxic intermediates but preserves insulin sensitivity

What caught our attention:  Continue reading Caught Our Notice: An “absolutely perfect retraction”

Caught Our Notice: Investigation finds “accidental mistakes” in PNAS stem cell paper

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of 1,000 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at [email protected].

Title: Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation 

What caught our attention: Continue reading Caught Our Notice: Investigation finds “accidental mistakes” in PNAS stem cell paper

Dispute over author order torpedoes paper on syndrome linked to autism

At least one disgruntled co-author has triggered the retraction of a paper presenting a novel approach to treating a rare, genetically inherited condition.

The paper concerned research on Fragile X syndrome (FXS), characterized by both intellectual and physical abnormalities, which is linked autism. A compound that passed through phase 2 clinical trials in October 2015 appeared to partially treat FXS in mice in the study, published earlier this year.

The journal’s notice says the paper was retracted over a dispute among authors about the order in which they are listed on the paper: Continue reading Dispute over author order torpedoes paper on syndrome linked to autism

A journal printed a sharp critique of a paper it had published. If only it had checked with the authors first.

In 2016, researchers published a paper showing that an RNA molecule may be overactive in breast tumor tissue. But after reading the paper, three biologists believed the data supported the opposite conclusion.

What happened after that is a tale of misunderstandings and unnecessarily bruised feelings. We’ve seen plenty of cases where researchers ignore criticism, which at first glance seemed to be the case here. But upon closer inspection, it wasn’t. Continue reading A journal printed a sharp critique of a paper it had published. If only it had checked with the authors first.

Journal issues note of concern, tips off university’s research integrity office

A journal has published an expression of concern (EoC) for a paper on cancer genetics in mice, over a concern about data in some gel panels.

The EoC for “Suppression of intestinal tumorigenesis in Apc mutant mice upon Musashi-1 deletion,” appeared Sept. 21 in Journal of Cell Science (JCS).

With the notice, the journal says:

Continue reading Journal issues note of concern, tips off university’s research integrity office

Board member resigns from journal over handling of paper accused of plagiarism

A biologist is crying foul at a journal’s decision to correct (and not retract) a paper he claims plagiarized his work — and one of his colleagues has resigned from the journal’s editorial board as a result.

The 2016 paper, published by Scientific Reports, is an application of a previously published algorithm designed to better identify regulatory sequences in DNA. The three authors, based at the Shenzhen campus of the Harbin Institute of Technology, used the technique to identify recombination spots in DNA. They called it SVM-gkm.

On April 2, Michael Beer of Johns Hopkins University in Baltimore notified the editors of Scientific Reports that he believed the paper had plagiarized his work. Despite Beer’s efforts, the journal ultimately decided to issue a correction notice, which cites “errors” and the authors’ failure to credit Beer’s work. That isn’t good enough for Beer — nor one of his colleagues at Johns Hopkins, who resigned from the journal’s editorial board saying “the recent affair with Mike Beer’s work being plagiarized did not impress me.”

Continue reading Board member resigns from journal over handling of paper accused of plagiarism

Journal to retract paper called “anti-vaccine pseudoscience”

A journal is planning to retract a paper that purported to link a component of vaccines to autism in mice.

The paper, about the effects of aluminum adjuvants in vaccines on the immune response in the brains of mice, is the second retraction for co-authors Christopher Shaw and Lucija Tomljenovic, of the University of British Columbia. The journal’s editor told us he and the authors are jointly retracting the paper. 

Just over a month old, the paper has already received plenty of criticism. Numerous commenters on PubPeer have allegedly identified image duplications and other problems with the paper. One commenter described “clear and deliberate” removal of control results in the paper, while others suggested gel bands were duplicated within the paper, and appear similar to those from another paper published in 2014 by Shaw and Tomljenovic. In a blog post, David Gorski, a professor and surgeon at Wayne State University, called the paper “antivaccine pseudoscience.”

Shaw, the paper’s last author, told us that his lab became aware of the PubPeer discussion a few weeks after publication:  Continue reading Journal to retract paper called “anti-vaccine pseudoscience”

Case report of stem cell therapy in child didn’t meet “ethical standards,” says journal

A journal has retracted a recent case report about a stem cell therapy in a child with cerebral palsy, after discovering the study failed to meet “ethical standards.”

According to the journal, Regenerative Medicine, the ethical issue is that the authors failed to report the case to the Ministry of Health, Labor and Welfare of Japan, which violates the country’s guidelines for conducting stem cell research. Unfortunately, we don’t know much more than that about what happened.

Laura Dormer, editorial director of Future Science Group, which publishes Regenerative Medicine, explained that the paper’s first author, Masato Kantake, requested the retraction because: Continue reading Case report of stem cell therapy in child didn’t meet “ethical standards,” says journal